GL Capital Group leads $290m investment in Chinese life sciences firm Sangon Biotech

GL Capital Group leads $290m investment in Chinese life sciences firm Sangon Biotech

Image from Sangon Biotech's official website

20 April, 2023

Edited by: Pramod Mathew

DNA synthesis gene sequencing GL Capital Group healthcare life sciences Sangon Biotech

Printed by Unregistered user on Wed, 10 Dec 2025 09:09:27 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Biotech firm Mirxes said to be looking at raising up to $200m in Singapore IPO

China’s healthcare deals struggle, but M&As expected to drive growth

Read more from Greater China

Venture Capital

Temasek, HongShan-backed D3 Bio raises $108m in Series B round

Earnings and Results

Chinese sovereign wealth fund CIC’s profit soars 30.4% on investment gains